Health Care Archives - Page 41 of 478

2 minute read

AstraZeneca’s Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows

April 16, 8:53 AM

AstraZeneca's updated data from TOPAZ-1 Phase 3 trial of Imfinzi (durvalumab) in advanced biliary tract cancer patients. Unveiling long-term survival benefits and significant overall survival improvement.

AZN

2 minute read

Investors Cheer UnitedHealth’s Q1 Earnings Despite Cyberattack Fallout, Taking $872M Hit From Hack

By Vandana Singh

April 16, 7:56 AM

UnitedHealth shares rise on strong Q1 2024 results. Revenue beats expectations at $99.8B. Operating income at $7.9 billion includes $872 million cyberattack impact.

UNH

2 minute read

J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play

By Surbhi Jain

April 15, 4:47 PM

Johnson & Johnson's Q1 earnings report on April 16 is expected to show $2.64 EPS and $21.4 billion in revenues. Technical analysis shows a bearish trend but analysts have a neutral rating with a $171.95 price target and potential 37.15% upside.

JNJ

2 minute read

Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA

By Vandana Singh

April 15, 2:42 PM

BofA Securities' upgrades Integer, highlighting the growth potential of pulsed field ablation (PFA) in atrial fibrillation treatment. With projections of PFA sales skyrocketing from $100-200 million in 2023 to over $2 billion in 2025, Integer emerges as a key supplier for major PFA device manufacturers

BSX

2 minute read

See How Florida’s Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina

By Vandana Singh

April 15, 2:17 PM

Florida announces Medicaid contract awards to Centene, Elevance Health, and Humana, sidelining UnitedHealth, CVS Health, and Molina. Details on MMA and LTC services for over 3.4 million Floridians enrolled.

CNC

1 minute read

Why Is Penny Stock Soligenix Trading Higher On Monday?

By Vandana Singh

April 15, 1:55 PM

Soligenix secures FDA orphan drug designation for MarVax, a vaccine against Marburg marburgvirus (MARV). Benefits include market exclusivity, financial perks, and potential FDA fee waivers. MARV, akin to Ebola, lacks approved vaccines, highlighting urgent need."

SNGX

1 minute read

Why Is Small-Cap Cancer Drug Developer Viracta Therapeutics Stock Trading Lower On Monday?

By Vandana Singh

April 15, 12:16 PM

Nanatinostat combined with valganciclovir shows promising results in treating relapsed or refractory EBV+ peripheral T-cell lymphoma, demonstrating higher efficacy and tolerability than nanatinostat monotherapy.

VIRX

2 minute read

Rare Disease-Focused-Ultragenyx Pharmaceutical Stock Falls On Serious Adverse Events In Eaarly Genetic Disorder Study

By Vandana Singh

April 15, 10:40 AM

New data from Phase 1/2 study of GTX-102 for Angelman syndrome shows rapid and sustained improvement in patients, exceeding natural history data.

RARE

2 minute read

Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?

By Vandana Singh

April 15, 10:17 AM

Neumora Therapeutics faces setbacks as FDA halts Phase 1 trial of NMRA-266 due to convulsion concerns in rabbits. Phase 1 study paused; company working with FDA for resolution.

NMRA

2 minute read

Why Did Epilepsy/Seizure Focused-Marinus Pharmaceuticals Stock Hit 52-Week Low On Monday?

By Vandana Singh

April 15, 10:13 AM

Marinus Pharmaceuticals provides updates on Phase 3 RAISE trial for refractory status epilepticus treatment with IV ganaxolone. With enrollment completion expected, topline results are anticipated by summer 2024.

MRNS